(1->4)-beta-D-glucan multiple interactions ISO Rbm39 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RBM39 mRNA CTD PMID:36331819 1,2-dimethylhydrazine multiple interactions ISO Rbm39 (Mus musculus) 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of RBM39 mRNA] CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO Rbm39 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of RBM39 mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO Rbm39 (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of RBM39 mRNA CTD PMID:17555576 17alpha-ethynylestradiol increases expression ISO Rbm39 (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of RBM39 mRNA CTD PMID:17942748 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RBM39 (Homo sapiens) 6480464 2 more ... CTD PMID:31675489 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RBM39 (Homo sapiens) 6480464 [Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in decreased expression of RBM39 mRNA CTD PMID:29704546 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of RBM39 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of RBM39 mRNA CTD PMID:32109520 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,4,6-tribromophenol decreases expression ISO RBM39 (Homo sapiens) 6480464 2 more ... CTD PMID:31675489 2-amino-2-deoxy-D-glucopyranose decreases expression ISO Rbm39 (Mus musculus) 6480464 Glucosamine results in decreased expression of RBM39 mRNA CTD PMID:17178593 2-butoxyethanol decreases expression ISO Rbm39 (Mus musculus) 6480464 n-butoxyethanol results in decreased expression of RBM39 mRNA CTD PMID:19812364 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RBM39 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of RBM39 mRNA CTD PMID:28628672 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1 and 2-dithiol-3-thione results in decreased expression of RBM39 mRNA CTD PMID:19162173 4,4'-sulfonyldiphenol multiple interactions ISO RBM39 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of RBM39 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of RBM39 mRNA CTD PMID:36041667 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of RBM39 mRNA CTD PMID:30047161 acetazolamide increases expression ISO Rbm39 (Mus musculus) 6480464 Acetazolamide results in increased expression of RBM39 mRNA CTD PMID:19274763 acrolein multiple interactions ISO RBM39 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RBM39 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RBM39 mRNA CTD PMID:32699268 acrylamide increases expression ISO RBM39 (Homo sapiens) 6480464 Acrylamide results in increased expression of RBM39 mRNA CTD PMID:32763439 aflatoxin B1 increases expression ISO Rbm39 (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of RBM39 mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO RBM39 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of RBM39 gene CTD PMID:27153756 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of RBM39 mRNA CTD PMID:23630614 aldehydo-D-glucosamine decreases expression ISO Rbm39 (Mus musculus) 6480464 Glucosamine results in decreased expression of RBM39 mRNA CTD PMID:17178593 alpha-pinene multiple interactions ISO RBM39 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RBM39 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RBM39 mRNA CTD PMID:32699268 amitrole decreases expression EXP 6480464 Amitrole results in decreased expression of RBM39 mRNA CTD PMID:30047161 aristolochic acid A decreases expression ISO RBM39 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of RBM39 mRNA CTD PMID:33212167 Aroclor 1254 decreases expression ISO Rbm39 (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of RBM39 mRNA CTD PMID:23650126 arsenite(3-) multiple interactions ISO RBM39 (Homo sapiens) 6480464 arsenite inhibits the reaction [G3BP1 protein binds to RBM39 mRNA] CTD PMID:32406909 benzo[a]pyrene diol epoxide I decreases expression ISO RBM39 (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 beta-D-glucosamine decreases expression ISO Rbm39 (Mus musculus) 6480464 Glucosamine results in decreased expression of RBM39 mRNA CTD PMID:17178593 bilirubin IXalpha decreases expression ISO RBM39 (Homo sapiens) 6480464 Bilirubin results in decreased expression of RBM39 mRNA CTD PMID:20196124 bis(2-chloroethyl) sulfide increases phosphorylation ISO RBM39 (Homo sapiens) 6480464 Mustard Gas results in increased phosphorylation of RBM39 protein CTD PMID:19845377 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of RBM39 mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of RBM39 mRNA CTD PMID:36041667 bisphenol A decreases expression ISO RBM39 (Homo sapiens) 6480464 bisphenol A results in decreased expression of RBM39 protein CTD PMID:31675489 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of RBM39 mRNA CTD PMID:36041667 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of RBM39 mRNA CTD PMID:19010381 and PMID:33453195 caffeine decreases phosphorylation ISO RBM39 (Homo sapiens) 6480464 Caffeine results in decreased phosphorylation of RBM39 protein CTD PMID:35688186 carbon nanotube decreases expression ISO RBM39 (Homo sapiens) 6480464 Nanotubes and Carbon results in decreased expression of RBM39 mRNA CTD PMID:24389112 carbon nanotube decreases expression ISO Rbm39 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of RBM39 mRNA CTD PMID:23125180 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of RBM39 mRNA CTD PMID:20691718 chrysene increases expression ISO Rbm39 (Mus musculus) 6480464 chrysene results in increased expression of RBM39 mRNA CTD PMID:26377693 copper(II) sulfate increases expression ISO RBM39 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of RBM39 mRNA CTD PMID:19549813 coumarin increases phosphorylation ISO RBM39 (Homo sapiens) 6480464 coumarin results in increased phosphorylation of RBM39 protein CTD PMID:35688186 curcumin increases expression ISO RBM39 (Homo sapiens) 6480464 Curcumin results in increased expression of RBM39 mRNA CTD PMID:17999991 cyclosporin A increases expression ISO RBM39 (Homo sapiens) 6480464 Cyclosporine results in increased expression of RBM39 mRNA CTD PMID:20106945 decabromodiphenyl ether decreases expression ISO RBM39 (Homo sapiens) 6480464 decabromobiphenyl ether results in decreased expression of RBM39 protein CTD PMID:31675489 deoxynivalenol increases phosphorylation ISO Rbm39 (Mus musculus) 6480464 deoxynivalenol results in increased phosphorylation of RBM39 protein CTD PMID:23811945 dexamethasone multiple interactions ISO RBM39 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of RBM39 mRNA CTD PMID:28628672 dibutyl phthalate decreases expression ISO Rbm39 (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of RBM39 mRNA CTD PMID:21266533 dicrotophos decreases expression ISO RBM39 (Homo sapiens) 6480464 dicrotophos results in decreased expression of RBM39 mRNA CTD PMID:28302478 diuron decreases expression EXP 6480464 Diuron results in decreased expression of RBM39 mRNA CTD PMID:21551480 diuron decreases expression ISO RBM39 (Homo sapiens) 6480464 Diuron results in decreased expression of RBM39 mRNA CTD PMID:35967413 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of RBM39 mRNA CTD PMID:29391264 ethanol decreases expression ISO Rbm39 (Mus musculus) 6480464 Ethanol results in decreased expression of RBM39 mRNA CTD PMID:29018328 ethanol affects splicing ISO Rbm39 (Mus musculus) 6480464 Ethanol affects the splicing of RBM39 mRNA CTD PMID:30319688 ferroheme b increases expression ISO Rbm39 (Mus musculus) 6480464 Heme metabolite results in increased expression of RBM39 mRNA CTD PMID:19191707 folic acid decreases expression ISO Rbm39 (Mus musculus) 6480464 Folic Acid results in decreased expression of RBM39 mRNA CTD PMID:25629700 folic acid multiple interactions ISO Rbm39 (Mus musculus) 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of RBM39 mRNA] CTD PMID:22206623 formaldehyde decreases expression ISO RBM39 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of RBM39 mRNA CTD PMID:20655997 FR900359 affects phosphorylation ISO RBM39 (Homo sapiens) 6480464 FR900359 affects the phosphorylation of RBM39 protein CTD PMID:37730182 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of RBM39 mRNA CTD PMID:22061828 and PMID:33387578 heme b increases expression ISO Rbm39 (Mus musculus) 6480464 Heme metabolite results in increased expression of RBM39 mRNA CTD PMID:19191707 hydrogen peroxide affects expression ISO RBM39 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of RBM39 mRNA CTD PMID:21179406 indometacin multiple interactions ISO RBM39 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of RBM39 mRNA CTD PMID:28628672 mercury dichloride decreases expression ISO RBM39 (Homo sapiens) 6480464 Mercuric Chloride results in decreased expression of RBM39 mRNA CTD PMID:27188386 methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of RBM39 mRNA CTD PMID:30047161 methylmercury chloride decreases expression ISO RBM39 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of RBM39 mRNA CTD PMID:28001369 microcystin-LR increases expression ISO Rbm39 (Mus musculus) 6480464 cyanoginosin LR results in increased expression of RBM39 protein CTD PMID:26984711 N-methyl-4-phenylpyridinium increases expression ISO Rbm39 (Mus musculus) 6480464 1-Methyl-4-phenylpyridinium results in increased expression of RBM39 protein CTD PMID:26558463 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of RBM39 mRNA CTD PMID:24136188 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of RBM39 mRNA CTD PMID:24136188 ozone multiple interactions ISO RBM39 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RBM39 mRNA more ... CTD PMID:32699268 paracetamol decreases expression ISO RBM39 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of RBM39 mRNA CTD PMID:21420995 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of RBM39 mRNA CTD PMID:19162173 perfluorooctane-1-sulfonic acid multiple interactions ISO Rbm39 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RBM39 mRNA CTD PMID:36331819 phenobarbital affects expression ISO RBM39 (Homo sapiens) 6480464 Phenobarbital affects the expression of RBM39 mRNA CTD PMID:19159669 phenobarbital affects expression ISO Rbm39 (Mus musculus) 6480464 Phenobarbital affects the expression of RBM39 mRNA CTD PMID:23091169 pirinixic acid decreases expression ISO Rbm39 (Mus musculus) 6480464 pirinixic acid results in decreased expression of RBM39 mRNA CTD PMID:17426115 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of RBM39 mRNA CTD PMID:19162173 and PMID:22484513 pirinixic acid increases expression ISO Rbm39 (Mus musculus) 6480464 pirinixic acid results in increased expression of RBM39 mRNA CTD PMID:16985257 and PMID:18445702 propiconazole decreases expression ISO Rbm39 (Mus musculus) 6480464 propiconazole results in decreased expression of RBM39 mRNA CTD PMID:21278054 propiconazole decreases expression EXP 6480464 propiconazole results in decreased expression of RBM39 mRNA CTD PMID:30047161 quercitrin increases expression ISO RBM39 (Homo sapiens) 6480464 quercitrin results in increased expression of RBM39 mRNA CTD PMID:25193878 quinomethionate affects expression ISO RBM39 (Homo sapiens) 6480464 quinomethionate affects the expression of RBM39 mRNA CTD PMID:15387888 resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of RBM39 mRNA CTD PMID:25905778 resveratrol multiple interactions ISO RBM39 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of RBM39 mRNA CTD PMID:23557933 silicon dioxide decreases expression ISO Rbm39 (Mus musculus) 6480464 Silicon Dioxide results in decreased expression of RBM39 mRNA CTD PMID:19073995 silicon dioxide increases expression ISO Rbm39 (Mus musculus) 6480464 Silicon Dioxide results in increased expression of RBM39 mRNA CTD PMID:19073995 sodium arsenate increases expression ISO Rbm39 (Mus musculus) 6480464 sodium arsenate results in increased expression of RBM39 mRNA CTD PMID:21795629 sodium arsenate decreases expression ISO Rbm39 (Mus musculus) 6480464 sodium arsenate results in decreased expression of RBM39 mRNA CTD PMID:30953684 streptozocin decreases expression EXP 6480464 Streptozocin results in decreased expression of RBM39 mRNA CTD PMID:25905778 succimer multiple interactions ISO Rbm39 (Mus musculus) 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RBM39 mRNA CTD PMID:21641980 sulfadimethoxine decreases expression EXP 6480464 Sulfadimethoxine results in decreased expression of RBM39 mRNA CTD PMID:30047161 sunitinib increases expression ISO RBM39 (Homo sapiens) 6480464 Sunitinib results in increased expression of RBM39 mRNA CTD PMID:31533062 tamoxifen affects expression ISO Rbm39 (Mus musculus) 6480464 Tamoxifen affects the expression of RBM39 mRNA CTD PMID:17555576 tetrahydropalmatine decreases expression ISO RBM39 (Homo sapiens) 6480464 tetrahydropalmatine results in decreased expression of RBM39 protein CTD PMID:20109541 tetrahydropalmatine increases expression ISO RBM39 (Homo sapiens) 6480464 tetrahydropalmatine results in increased expression of RBM39 protein CTD PMID:20109541 tetraphene increases expression ISO Rbm39 (Mus musculus) 6480464 benz(a)anthracene results in increased expression of RBM39 mRNA CTD PMID:26377693 thapsigargin increases expression ISO Rbm39 (Mus musculus) 6480464 Thapsigargin results in increased expression of RBM39 protein CTD PMID:24648495 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of RBM39 mRNA CTD PMID:34492290 torcetrapib increases expression ISO RBM39 (Homo sapiens) 6480464 torcetrapib results in increased expression of RBM39 mRNA CTD PMID:23228038 Tributyltin oxide decreases phosphorylation ISO Rbm39 (Mus musculus) 6480464 bis(tri-n-butyltin)oxide results in decreased phosphorylation of RBM39 protein CTD PMID:22174045 trichostatin A decreases expression ISO RBM39 (Homo sapiens) 6480464 trichostatin A results in decreased expression of RBM39 mRNA CTD PMID:24935251 trichostatin A affects expression ISO RBM39 (Homo sapiens) 6480464 trichostatin A affects the expression of RBM39 mRNA CTD PMID:28542535 triptonide affects expression ISO Rbm39 (Mus musculus) 6480464 triptonide affects the expression of RBM39 mRNA CTD PMID:33045310 valproic acid decreases expression ISO Rbm39 (Mus musculus) 6480464 Valproic Acid results in decreased expression of RBM39 mRNA CTD PMID:20546886 valproic acid decreases expression ISO RBM39 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of RBM39 mRNA CTD PMID:23179753 and PMID:27188386 valproic acid affects expression ISO RBM39 (Homo sapiens) 6480464 Valproic Acid affects the expression of RBM39 mRNA CTD PMID:25979313 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of RBM39 mRNA CTD PMID:19015723 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of RBM39 mRNA CTD PMID:23034163 vorinostat decreases expression ISO RBM39 (Homo sapiens) 6480464 vorinostat results in decreased expression of RBM39 mRNA CTD PMID:22083351 and PMID:27188386 zinc atom multiple interactions ISO RBM39 (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in decreased expression of RBM39 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RBM39 (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in decreased expression of RBM39 mRNA CTD PMID:18593933